Sunday, July 6, 2025 7/6/2025

Eastern Cooperative Oncology Group

Award Number: U10CA027525
ORGANIZATION: NATIONAL CANCER INSTITUTE
OPDIV: NIH
AWARD CLASS: COOPERATIVE AGREEMENT
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 06/01/1979
PERIOD OF PERFORMANCE END DATE: 02/28/2015

Group Awards By:

View Award Description

Eastern Cooperative Oncology Group - DESCRIPTION (provided by applicant): The Fox Chase Cancer Center (FCCC) demonstrates a continued commitment to clinical cancer research through administrative and scientific involvement with the Eastern Cooperative Oncology Group (ECOG). Participation in the ECOG clinical research programs is an integral component of the cancer research performed at FCCC. Active participation in ECOG activities provides an opportunity for our patients to participate in controlled multidisciplinary trials which are designed to provide the best potential new therapies for a variety of different types of cancer. In turn, FCCC performs an important role in defining the merits of these new therapies. ECOG also provides an important opportunity for the Developmental Therapeutics Molecular Medical program at our Center to interact with a larger number of clinical investigators interested in testing new and innovative therapies to improve survival and increase the cure rate for many different cancers. The Cooperative Group Outreach Program (CGOP) provides the opportunity to support our active affiliates, and their critical data management and nurse oncology functions. Through this program we make available to the community the most current therapeutic options and in turn these treatments are tested in the environment in which they will be most widely applied. The primary objectives of this grant are to (1) maintain a level of accrual to ECOG studies; (2) increase the level of multidisciplinary involvement by integrating key modality-oriented individuals into ECOG activity In our affiliate institutions; (3) Increase our contribution to the scientific activities of ECOG, and (4) maintain a high level of scientific and administrative Involvement In ECOG programs. During the next 6 year period, we anticipate growth In our ECOG accrual and In the impact we have on the scientific activities of the Group. RELEVANCE: The funding of this grant to Fox Chase Cancer Center (FCCC) provides opportunities for advancement of novel therapeutics to be evaluated in controlled clinical trials. The Eastern Cooperative Oncology Group (ECOG) is the sum of its component cancer center members. The scientific rationale, protocol development and accrual depend on the contribution of the investigators at FCCC. Taken together this will promote the development of new therapies to improve the outcomes for patients with malignancies.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2017 ( Subtotal = $0 )
2017	2012	FOX CHASE CANCER CENTER	333 COTTMAN AVE	PHILADELPHIA	PA	19111	PHILADELPHIA	USA	Cancer Treatment Research	000	34	5/8/2017	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2015 ( Subtotal = $0 )
2015	2013	INSTITUTE FOR CANCER RESEARCH	333 Cottman Ave	Philadelphia	PA	19111	PHILADELPHIA	USA	Cancer Treatment Research	000	36	1/27/2015	CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION	$57,352
2015	2013	INSTITUTE FOR CANCER RESEARCH	333 Cottman Ave	Philadelphia	PA	19111	PHILADELPHIA	USA	Cancer Treatment Research	001	36	1/28/2015	CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION	-$57,352
														Subtotal = $0

Issue Date FY: 2013 ( Subtotal = $362,721 )
2013	2013	FOX CHASE CANCER CENTER	333 Cottman Ave	Philadelphia	PA	19111	PHILADELPHIA	USA	Cancer Treatment Research	000	35	5/16/2013	NON-COMPETING CONTINUATION	$76,171
2013	2013	INSTITUTE FOR CANCER RESEARCH	333 Cottman Ave	Philadelphia	PA	19111	PHILADELPHIA	USA	Cancer Treatment Research	006	36	9/12/2013	CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION	$362,721
2013	2013	FOX CHASE CANCER CENTER	7701 BURHOLME AVE	PHILADELPHIA	PA	19111	PHILADELPHIA	USA	Cancer Treatment Research	005	35	9/11/2013	NON-COMPETING CONTINUATION	$0
2013	2013	FOX CHASE CANCER CENTER	333 Cottman Ave	Philadelphia	PA	19111	PHILADELPHIA	USA	Cancer Treatment Research	001	35	7/31/2013	NON-COMPETING CONTINUATION	-$76,171
2013	2013	FOX CHASE CANCER CENTER	333 Cottman Ave	Philadelphia	PA	19111	PHILADELPHIA	USA	Cancer Treatment Research	004	35	9/6/2013	NON-COMPETING CONTINUATION	-$362,721
2013	2013	FOX CHASE CANCER CENTER	7701 BURHOLME AVE	PHILADELPHIA	PA	19111	PHILADELPHIA	USA	Cancer Treatment Research	003	35	8/7/2013	NON-COMPETING CONTINUATION	$0
2013	2013	FOX CHASE CANCER CENTER	333 Cottman Ave	Philadelphia	PA	19111	PHILADELPHIA	USA	Cancer Treatment Research	002	35	8/6/2013	NON-COMPETING CONTINUATION	$362,721
														Subtotal = $362,721

Issue Date FY: 2012 ( Subtotal = $408,206 )
2012	2012	FOX CHASE CANCER CENTER	333 Cottman Ave	Philadelphia	PA	19111	PHILADELPHIA	USA	Cancer Treatment Research	000	34	5/10/2012	NON-COMPETING CONTINUATION	$319,919
2012	2012	FOX CHASE CANCER CENTER	333 Cottman Ave	Philadelphia	PA	19111	PHILADELPHIA	USA	Cancer Treatment Research	001	34	7/30/2012	NON-COMPETING CONTINUATION	$88,287
														Subtotal = $408,206

Issue Date FY: 2011 ( Subtotal = $408,206 )
2011	2011	FOX CHASE CANCER CENTER	333 Cottman Ave	Philadelphia	PA	19111	PHILADELPHIA	USA	Cancer Treatment Research	000	33	4/21/2011	NON-COMPETING CONTINUATION	$408,206
														Subtotal = $408,206

Issue Date FY: 2010 ( Subtotal = $448,725 )
2010	2010	FOX CHASE CANCER CENTER	333 Cottman Ave	Philadelphia	PA	19111	PHILADELPHIA	USA	Cancer Treatment Research	000	32	5/1/2010	COMPETING CONTINUATION	$448,725
														Subtotal = $448,725

Issue Date FY: 2009 ( Subtotal = $453,259 )
2009	2009	FOX CHASE CANCER CENTER	333 Cottman Ave	Philadelphia	PA	19111	PHILADELPHIA	USA	Cancer Treatment Research	000	31	5/1/2009	NON-COMPETING CONTINUATION	$453,259
														Subtotal = $453,259

Issue Date FY: 2008 ( Subtotal = $445,682 )
2008	2008	FOX CHASE CANCER CENTER	7701 BURHOLME AVE	PHILADELPHIA	PA	19111	PHILADELPHIA	USA	Cancer Treatment Research	000	30	4/18/2008	NON-COMPETING CONTINUATION	$445,682
														Subtotal = $445,682

Issue Date FY: 2007 ( Subtotal = $445,682 )
2007	2007	FOX CHASE CANCER CENTER	7701 BURHOLME AVE	PHILADELPHIA	PA	19111	PHILADELPHIA	USA	Cancer Treatment Research	000	29	9/14/2007	NON-COMPETING CONTINUATION	$445,682
														Subtotal = $445,682

Issue Date FY: 2006 ( Subtotal = $445,682 )
2006	2006	FOX CHASE CANCER CENTER	7701 BURHOLME AVE	PHILADELPHIA	PA	19111	PHILADELPHIA	USA	Cancer Treatment Research	000	28	7/19/2006	NON-COMPETING CONTINUATION	$445,682
														Subtotal = $445,682

Issue Date FY: 2004 ( Subtotal = $489,398 )
2004	2004	FOX CHASE CANCER CENTER	7701 BURHOLME AVE	PHILADELPHIA	PA	19111	PHILADELPHIA	USA	Cancer Treatment Research	000	26	8/13/2004	COMPETING CONTINUATION	$489,398
														Subtotal = $489,398

Issue Date FY: 2003 ( Subtotal = $489,398 )
2003	2003	FOX CHASE CANCER CENTER	7701 BURHOLME AVE	PHILADELPHIA	PA	19111	PHILADELPHIA	USA	Cancer Treatment Research	000	25		NON-COMPETING CONTINUATION	$489,398
														Subtotal = $489,398

Issue Date FY: 2002 ( Subtotal = $485,561 )
2002	2002	FOX CHASE CANCER CENTER	7701 BURHOLME AVE	PHILADELPHIA	PA	19111	PHILADELPHIA	USA	Cancer Treatment Research	000	24	4/26/2002	NON-COMPETING CONTINUATION	$485,561
														Subtotal = $485,561

Issue Date FY: 2001 ( Subtotal = $433,599 )
2001	2001	FOX CHASE CANCER CENTER	7701 BURHOLME AVE	PHILADELPHIA	PA	19111	PHILADELPHIA	USA	Cancer Treatment Research	000	23	5/18/2001	NON-COMPETING CONTINUATION	$433,599
														Subtotal = $433,599

Issue Date FY: 2000 ( Subtotal = $458,517 )
2000	2000	FOX CHASE CANCER CENTER	7701 BURHOLME AVE	PHILADELPHIA	PA	19111	PHILADELPHIA	USA	Cancer Treatment Research	000	22	4/26/2000	NON-COMPETING CONTINUATION	$458,517
														Subtotal = $458,517

Issue Date FY: 1999 ( Subtotal = $446,441 )
1999	1999	FOX CHASE CANCER CENTER	7701 BURHOLME AVE	PHILADELPHIA	PA	19111	PHILADELPHIA	USA	Cancer Treatment Research	000	21	5/13/1999	COMPETING CONTINUATION	$446,441
														Subtotal = $446,441

Issue Date FY: 1998 ( Subtotal = $433,223 )
1998	1998	FOX CHASE CANCER CENTER	7701 BURHOLME AVE	PHILADELPHIA	PA	19111	PHILADELPHIA	USA	Cancer Treatment Research	000	20	4/14/1998	NON-COMPETING CONTINUATION	$433,223
														Subtotal = $433,223

Grand Total All Awards = $6,654,300

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Eastern Cooperative Oncology Group

Award Number: U10CA027525

ORGANIZATION: NATIONAL CANCER INSTITUTE

OPDIV: NIH

AWARD CLASS: COOPERATIVE AGREEMENT

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 06/01/1979

PERIOD OF PERFORMANCE END DATE: 02/28/2015

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer